Jump to content

Prescribed Drug Dependence Project in the UK - please sign sign up


Caspur

Recommended Posts

Please can subscribers to this forum sign up to the email updates from the http://prescribeddrug.org/ site? I have started a social media campaign via various existing Facebook groups (closed support groups, mostly) to try to get more people subscribed. There are many thousands of people on this forum who will benefit from the work this organisation are doing. I do appreciate many people have their own struggles and are in countries far away from the UK, but I'm sure the results of their work will have an impact outside the UK in the medium to long term. Lets show them there's a lot of interest in what they are doing 🙌

Many thanks

Caspur

2011 - started Venlafaxine (again) at 75mg Raised to 150 mg at some point - unsure of dates. Reduced back down to 75 mg. Doctor advised this would be a lifetime, maintenance dose

2017 - Side effects now intolerable. Started taper from June 15th - 5% dose reduction steps (two 12 hourly doses).

2017 - October 20th - took last dose of Venlafaxine - 4 mg. Debilitating symptoms followed.

2017/18 - diazepam - 8mg/day for 1 month - 7 week taper Feb 2018

2017/18 - duloxetine - max 90mg - now stopped

2018 - Feb 25mg quetiapine, increased to 50mg.

2018 - March/April - increased venlafaxine slowly (10mg steps) to 75 mg/day. Recovery from withdrawal followed.

2018 - July 13 - stopped quetiapine after 2 month taper. Late July - had to reinstate quetiapine due to intolerable withdrawal. Now tapering from 25mg

2019 - June - stopped quetiapine after 10 month taper. Mild insomnia only symptom.

2021 - June - venlafaxine approx 6.0 mg see Taper history details

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

Terms of Use Privacy Policy